The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritis

Arthritis & Rheumatism

Volumn 33, Issue 1, 1990, Pages 9-18

  Morgan, Sarah L ^a   Baggott, Joseph E ^a   Vaughn, William H ^a   Young, Peggy K ^a   Austin, Janet V ^a   Krumdieck, Carlos L ^a   Alarcon, Graciela S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHOTREXATE;

ADULT; AGED; ALOPECIA; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CYTOPENIA; FEMALE; HUMAN; LIVER TOXICITY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STOMATITIS;

ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FOLIC ACID; HUMAN; METHOTREXATE; PATIENT DROPOUTS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025037994     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780330102     Document Type: Article

References (65)

1. Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis.
2. A controlled two‐centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.
3. Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunologic effects in a randomized, double‐blind study.
4. Efficacy of lowdose methotrexate in rheumatoid arthritis.
5. Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial.
6. The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis.
7. Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritis.
8. Methotrexate in rheu matoid arthritis: indications, contraindications, efficacy, and safety.
9. Two year follow‐up of efficacy and toxicity of methotrexate therapy in rheumatoid arthritis (abstract).
10. Toxicity to methotrexate in rheumatoid arthritis.
11. 12
12. 1958 revision of diagnostic criteria for rheumatoid arthritis
13. Carpo:metacarpal ratio: a new quantitative measure of radiologic progression of wrist involvement in rheumatoid arthritis.
14. The carpometacarpal ratio: a useful method for assessing disease progression in rheumatoid arthritis.
15. Low‐dose d‐penicillamine therapy in rheumatoid arthritis: a controlled, doubleblind clinical trial.
16. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial.
17. Folate status of rheumatoid arthritis patients receiving long‐term, lowdose methotrexate therapy.
18. Deficient folate activity during treatment of psoriasis with methotrexate diagnosed by determination of serine synthesis in lymphocytes.
19. Committee on Dietary Allowances, Food and Nutrition Board, Division of Biological Sciences, National Research Council
20. Nutrient intake supplementation in the United States (NHANES II).
21. Vitamin and mineral supplement use in the United States.
22. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients.
23. Treatment of psoriasis with methotrexate and folinic acid.
24. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis.
25. The use of leucovorin after low dose methotrexate in patients with rheumatoid arthritis (abstract).
26. Beneficial effects of leucovorin after methotrexate treatment in rheumatoid arthritis: a case report (letter).
27. Resistant rheumatoid arthritis: what to do when conservative therapy doesn't work.
28. Methotrexate therapy in rheumatoid arthritis: current status.
29. Methotrexate in rheumatoid arthritis.
30. Methotrexate: its use in the rheumatic diseases.
31. Hypothesis: auto‐immune complications of d‐penicillamine: a possible result of zinc and magnesium depletion and pyridoxine inactivation.
32. Do trace elements, magnesium and anti‐oxidants protect against d‐penicillamine toxicity?
33. Serum folate activity in patients with tumors of the head and neck treated with methotrexate (abstract).
34. Methotrexate hepatotoxicity in psoriasis: consideration of liver biopsies at regular intervals.
35. Liver biopsy in psoriasis.
36. Methotrexate hepatotoxicity in psoriasis: comparison of different dose regimens.
37. Psoriasis‐liver‐methotrexate interactions.
38. The clinical pharmacology of methotrexate: new applications of an old drug.
39. Interrelationship of rheumatoid arthritis, folic acid, and aspirin.
40. Folic acid deficiency in rheumatoid arthritis.
41. Methotrexate for psoriasis in weekly oral doses.
42. Methotrexate in the treatment of corticosteroid‐dependent asthma: a doubleblind crossover study.
43. Primary sclerosing cholangitis and low‐dose oral pulse methotrexate therapy: clinical and histologic response.
44. 12 deficient humans.
45. 12 levels in rheumatoid arthritis (abstract).
46. Sulphasalazine in rheumatoid arthritis.
47. Sulfasalazine in rheumatoid arthritis: a double‐blind, place‐bo‐controlled trial.
48. Antifolate actions of sulfasalazine on intact lymphocytes.
49. Methotrexate toxicity in a patient receiving trimethoprim‐sulfamethoxazole.
50. Methotrexate toxicity in a patient receiving trimethoprim‐sulfamethoxazole.
51. Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim‐sulfamethoxazole treatment.
52. Pancytopenia in duced by the interaction between methotrexate and trimethoprim‐sulfamethoxazole.
53. One‐carbon metabolism in lectin‐activated human lymphocytes.
54. Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis.
55. Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate.
56. Antifolates: expanding horizons in 1986
57. The effect of methotrexate on folate metabolism in the rat.
58. Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug.
59. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: association with hepatic folate deficiency and formation of polyglutamates.
60. Comment on the letter by Jaffe (letter).